The human heart is at the center of a remarkable moment in medicine and public health. Cardiovascular disease remains the world’s leading killer, taking an estimated 19.8 million lives in 2022 alone, roughly 32% of all deaths on Earth. Yet at the same time, breakthroughs in gene editing, animal-to-human transplants, and artificial intelligence are reshaping what’s possible for a failing heart. Here’s what’s been happening across every front.
Heart Disease Still Dominates Global Death Counts
Despite decades of public health campaigns, heart disease hasn’t loosened its grip. The World Health Organization reports that 85% of cardiovascular deaths are caused by heart attacks and strokes. More than three quarters of those deaths occur in low- and middle-income countries, where access to prevention and emergency care is limited. Among people who die prematurely from noncommunicable diseases (before age 70), at least 38% are killed by cardiovascular conditions.
These numbers have not dramatically improved in recent years. Sedentary lifestyles are a major driver. Research published in the Canadian Journal of Cardiology identified thresholds that matter: sitting for more than 4 hours a day was linked to a 14% higher risk of total cardiac events, and exceeding 10 hours of daily sedentary time raised the risk of major adverse cardiac events by 18%. For many people working desk jobs, those numbers are alarmingly easy to hit.
What Actually Happens During a Heart Attack
A heart attack unfolds faster than most people realize. Within seconds of blood flow being cut off to heart muscle, cells begin to change at the microscopic level. Muscle fibers relax, energy stores drain, and mitochondria (the tiny engines inside each cell) start to swell. For the first 30 minutes, this damage is still reversible if blood flow is restored.
After 30 minutes, the injury crosses a line. Cell membranes begin to break apart, and the damage becomes permanent. Between 4 and 12 hours, tissue death becomes visible, with the affected area darkening as cells die and fluid accumulates. By 12 to 24 hours, the dead zone is fully established, with immune cells flooding in to clean up the destruction. Dead heart fibers get pulled and distorted by the still-living fibers next to them, which keep contracting with each heartbeat. This is why the speed of treatment during a heart attack matters so much: every minute past that 30-minute window means more muscle that can never recover.
COVID-19 Left a Mark on the Heart
The pandemic introduced a new cardiac threat that cardiologists are still tracking. A large meta-analysis covering more than 36,000 patients found that about 1.2% of people with acute COVID-19 developed myocarditis, an inflammation of the heart muscle. That number jumped to 7.4% in people experiencing long COVID symptoms. Children who developed the inflammatory syndrome known as MIS-C were hit hardest, with myocarditis rates near 32%.
These weren’t always mild cases. Among those who developed myocarditis, 22% showed reduced heart pumping ability, and 15% experienced dangerous irregular heart rhythms. For most adults, the acute risk was low, but the post-infection numbers suggest that millions of people worldwide may have experienced some degree of heart inflammation without knowing it, particularly during early waves when testing and awareness were limited.
Women’s Heart Attacks Are Still Being Missed
One of the most persistent failures in cardiac care is the diagnostic gap for women. Women experiencing heart attacks are frequently misdiagnosed with asthma or anxiety, leading to dangerous delays in treatment. This pattern holds across multiple types of heart disease, including acute coronary syndromes, heart failure, and valve disease. Women consistently receive less aggressive treatment and are less likely to be referred to cardiac rehabilitation compared to men.
The core problem is that the “classic” heart attack presentation, crushing chest pain radiating down the left arm, was defined by studying men. Women more often experience shortness of breath, chest pressure or discomfort rather than sharp pain, nausea, and fatigue. When these symptoms don’t match the textbook picture, they get attributed to stress or panic. Implicit biases based on sex, age, race, and appearance compound the problem further.
Gene Editing Targets Heart Disease at Its Source
One of the most striking recent developments is the use of CRISPR gene editing to attack cardiovascular risk factors with a single treatment. A first-in-human trial at the Cleveland Clinic tested a therapy called CTX310, delivered as a one-time infusion. The treatment sends CRISPR editing tools to the liver, where they switch off a gene responsible for producing a protein that raises cholesterol and triglyceride levels.
The results from the 15-patient trial were notable. Within two weeks, LDL cholesterol dropped by about 50% and triglycerides fell by roughly 55% at the highest dose. Those reductions held for at least 60 days, with follow-up still ongoing. Side effects were mild: three participants had temporary back pain or nausea, and one person with pre-existing liver enzyme elevations saw a brief spike that resolved on its own within days. No serious treatment-related adverse events occurred. If these results hold up in larger trials, a single infusion could replace a lifetime of daily cholesterol medication for some patients.
Pig Hearts in Human Chests
In 2022, surgeons made history by transplanting a genetically modified pig heart into a human patient. The organ functioned for weeks, but the case ultimately ended in the patient’s death on day 60. The pig heart began to thicken and fail on day 49, nearly doubling in weight from fluid buildup. An autopsy revealed scattered cell death and swelling, but not the typical pattern of immune rejection that transplant teams most feared.
A key complication was a pig virus, porcine cytomegalovirus, first detected in the patient’s blood on day 20. The virus likely contributed to the organ’s deterioration. The case proved that a pig heart can support human circulation for a meaningful period, but also revealed that infection screening and organ preservation need to advance significantly before xenotransplantation becomes a realistic option for the roughly 100,000 people waiting for donor organs in the United States at any given time.
AI Now Reads Heart Scans Better Than Cardiologists
Artificial intelligence has quietly crossed a threshold in cardiac diagnostics. A model published in Nature called EchoNext, designed to detect structural heart disease from standard electrocardiograms, achieved 77.3% accuracy with 72.6% sensitivity and 80.7% specificity. Board-certified cardiologists reading the same ECGs without AI assistance managed 64.0% accuracy. When cardiologists were given the AI’s analysis to assist their interpretation, their accuracy rose to 69.2%.
The practical implication is significant. ECGs are among the most common and inexpensive cardiac tests performed worldwide. An AI layer that catches structural problems a human reader might miss could flag disease earlier, particularly in settings where specialist cardiologists aren’t available. The technology doesn’t replace a doctor’s judgment, but it meaningfully narrows the gap between a rural clinic and a major medical center.
How the Heart Got Its Four Chambers
The human heart didn’t always look the way it does now. Early in embryonic development, every human heart passes through a tube-shaped stage with just three compartments, echoing an ancient evolutionary blueprint shared across vertebrates. Fish still use a version of this tubular heart, with a simple chamber pushing blood in one direction through the gills.
The transition to four separate chambers happened gradually across evolutionary time. Lungfish represent a middle step, with partial walls beginning to divide both the upper and lower chambers, allowing partial separation of oxygen-rich and oxygen-poor blood. Full separation into four distinct chambers, two upper atria and two lower ventricles, evolved independently in only three lineages: crocodilians, birds, and mammals. This design allows completely separate circuits for the lungs and the rest of the body, supporting the high metabolic demands of warm-blooded life. It’s a solution that took hundreds of millions of years to arrive at, and every human heart briefly replays that journey during the first weeks of fetal development.